As clinicians recognize the importance of controlling a full spectrum of comorbidities linked to cardiometabolic events, David Calabrese, RPh, MHP, highlights the benefits of new single-agents and explains how these options treat multiple components.
Yehuda Handelsman, MD, FACP, FACE, FNLA, explains that as different formulations with different delivery systems evolve, they offer additional benefits to clinicians and patients.
For example, Dr Handelsman points out that when delivering insulin for the treatment of diabetes, new agents can be administered through a pen option instead of a syringe. Additionally, he explains that many new agents are long-acting, offering more convenience to patients.
Concerned about the differences in cost between older and newer agents, Kenneth L. Schaecher, MD, FACP, CPC, questions Dr Handelsman about the significance of utilizing the pen rather than
the syringe as a delivery option.
Dr Handelsman explains that although the pen option is a more expensive delivery option, the accuracy of the pen has been acknowledged in many settings, including the hospital setting, and has helped improve glycemic goals.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More